TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 61 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $241,835 | -5.1% | 6,413 | -4.5% | 0.00% | – |
| Q2 2023 | $254,814 | +749.4% | 6,718 | +449.8% | 0.00% | – |
| Q1 2023 | $30,000 | +115284.6% | 1,222 | +33.3% | 0.00% | – |
| Q4 2022 | $26 | -99.9% | 917 | -13.2% | 0.00% | – |
| Q3 2022 | $31,000 | -74.4% | 1,057 | -68.4% | 0.00% | – |
| Q2 2022 | $121,000 | +245.7% | 3,340 | +308.8% | 0.00% | – |
| Q1 2022 | $35,000 | -82.5% | 817 | -79.5% | 0.00% | – |
| Q4 2021 | $200,000 | -75.5% | 3,995 | -68.8% | 0.00% | – |
| Q3 2021 | $815,000 | -62.9% | 12,801 | -58.1% | 0.00% | – |
| Q2 2021 | $2,196,000 | -11.8% | 30,528 | -9.6% | 0.00% | – |
| Q1 2021 | $2,491,000 | +218.5% | 33,776 | +217.0% | 0.00% | – |
| Q4 2020 | $782,000 | +19.8% | 10,655 | -11.0% | 0.00% | – |
| Q3 2020 | $653,000 | +161.2% | 11,976 | +218.2% | 0.00% | – |
| Q2 2020 | $250,000 | -88.1% | 3,764 | -89.0% | 0.00% | – |
| Q1 2020 | $2,099,000 | -50.9% | 34,298 | -29.4% | 0.00% | -100.0% |
| Q4 2019 | $4,272,000 | +108.7% | 48,586 | +79.1% | 0.00% | – |
| Q3 2019 | $2,047,000 | +5.8% | 27,125 | +19.9% | 0.00% | – |
| Q2 2019 | $1,934,000 | +56.5% | 22,627 | +98.0% | 0.00% | – |
| Q1 2019 | $1,236,000 | -21.3% | 11,430 | -38.4% | 0.00% | – |
| Q4 2018 | $1,570,000 | -19.7% | 18,549 | -6.6% | 0.00% | – |
| Q3 2018 | $1,954,000 | -21.3% | 19,863 | -7.4% | 0.00% | -100.0% |
| Q2 2018 | $2,483,000 | -41.2% | 21,459 | -49.8% | 0.00% | 0.0% |
| Q1 2018 | $4,224,000 | -4.9% | 42,771 | +0.8% | 0.00% | 0.0% |
| Q4 2017 | $4,442,000 | +151.8% | 42,413 | +169.2% | 0.00% | – |
| Q3 2017 | $1,764,000 | +24.3% | 15,757 | +24.5% | 0.00% | – |
| Q2 2017 | $1,419,000 | -10.9% | 12,661 | -7.3% | 0.00% | – |
| Q1 2017 | $1,592,000 | +16.7% | 13,657 | +5.4% | 0.00% | – |
| Q4 2016 | $1,364,000 | +15.5% | 12,952 | +21.1% | 0.00% | – |
| Q3 2016 | $1,181,000 | -36.1% | 10,692 | -15.7% | 0.00% | – |
| Q2 2016 | $1,848,000 | -14.4% | 12,690 | -15.8% | 0.00% | -100.0% |
| Q1 2016 | $2,160,000 | +666.0% | 15,079 | +729.0% | 0.00% | – |
| Q4 2015 | $282,000 | – | 1,819 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 565,951 | $24,483,000 | 8.44% |
| Murchinson Ltd. | 162,703 | $7,039,000 | 1.34% |
| Eversept Partners, LP | 220,286 | $9,529,572 | 0.73% |
| BRANDES INVESTMENT PARTNERS, LP | 379,322 | $16,410,000 | 0.35% |
| Analyst IMS Investment Management Services Ltd. | 17,657 | $764,000 | 0.07% |
| Claret Asset Management Corp | 7,279 | $315,000 | 0.06% |
| ACADIAN ASSET MANAGEMENT LLC | 326,427 | $14,086,000 | 0.06% |
| Renaissance Technologies | 678,300 | $29,343,000 | 0.03% |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | 191,820 | $8,298,000 | 0.03% |
| ARK Investment Management | 55,566 | $2,404,000 | 0.01% |